top of page
Browse by category
Search
Structure Therapeutics selects oral small molecule amylin receptor agonist ACCG-2671 for obesity treatment
Structure Therapeutics has selected its lead oral small molecule amylin receptor agonist, ACCG-2671, which the company will develop for...
Structure announces positive results from oral GLP-1 receptor agonist gsbr-1290
Structure Therapeutics has announced positive results from the Phase 1b multiple ascending dose (MAD) study of its highly selective oral...
Browse by tag
bottom of page